Investigational Biologic Agent May Reduce Severe Asthma Exacerba...

You can't request more than 20 challenges without solving them. Your previous challenges were flushed.
Courtesy MedPage Today Allergy & Immunology  Wed, 03/04/2009 - 15:00

HAMILTON, Ontario (MedPage Today) -- The experimental monoclonal antibody mepolizumab (Bosatria) may reduce corticosteroid requirements and exacerbations in patients with severe refractory asthma.


 

More related items

Traffic-Related Asthma Costs Underestimated (CME/CE)
(MedPage Today) -- The impact that motor vehicle exhaust has on asthma costs is much bigger than once thought, researchers warned.

Early Infant Weight Gain Tied to Asthma (CME/CE)
(MedPage Today) -- Rapid weight gain during the first months of life is associated with an increased risk of asthma, a prospective Dutch cohort study suggested.

Mobile Asthma Clinic of Little Benefit to Kids...
(MedPage Today) -- A program intended to improve access to care for children with asthma, which included a mobile clinic called the Breathmobile, led to slight and transient benefits, a...

Finger Pulse Oximeter Octive Tech 300C with Hard...
OctiveTech 300C Digital Finger Pulse Oximeter combines advanced technology with a stylish, wearable design. The outstanding interference resistance capacity against ambient light along with...

Burt's Bees - Baby Bee Buttermilk Lotion, 7 fl oz...
Baby Bee Buttermilk Lotion contains only Mother Nature's safe and gentle ingredients, and is enriched with vitamin E, Aloe Vera and Buttermilk to provide soothing and nourishing emollients...


 

Post new comment

The content of this field is kept private and will not be shown publicly.
health-fitness.marc8.com